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Background: Ischemia/reperfusion (I/R) injury, involved in primary graft dysfunction following lung transplantation,
leads to inactivation of intra-alveolar surfactant which facilitates injury of the blood-air barrier. The alveolar
epithelial type II cells (AE2 cells) synthesize, store and secrete surfactant; thus, an intracellular surfactant pool stored
in lamellar bodies (Lb) can be distinguished from the intra-alveolar surfactant pool. The aim of this study was to
investigate ultrastructural alterations of the intracellular surfactant pool in a model, mimicking transplantation-
related procedures including flush perfusion, cold ischemia and reperfusion combined with mechanical ventilation.
Methods: Using design-based stereology at the light and electron microscopic level, number, surface area and
mean volume of AE2 cells as well as number, size and total volume of Lb were determined in a group subjected
to transplantation-related procedures including both I/R injury and mechanical ventilation (I/R group) and a control
group.
Results: After I/R injury, the mean number of Lb per AE2 cell was significantly reduced compared to the control
group, accompanied by a significant increase in the luminal surface area per AE2 cell in the I/R group. This increase
in the luminal surface area correlated with the decrease in surface area of Lb per AE2. The number-weighted mean
volume of Lb in the I/R group showed a tendency to increase.
Conclusion: We suggest that in this animal model the reduction of the number of Lb per AE2 cell is most likely
due to stimulated exocytosis of Lb into the alveolar space. The loss of Lb is partly compensated by an increased
size of Lb thus maintaining total volume of Lb per AE2 cell and lung. This mechanism counteracts at least in part
the inactivation of the intra-alveolar surfactant.
Background
Primary graft dysfunction is a major cause of short- and
long-term mortality and morbidity following clinical
lung transplantation, and affects approximately 15% of
patients [1,2]. The clinical presentation ranges from
mild acute lung injury to severe acute respiratory dis-
tress syndrome [3]. The ischemia/reperfusion injury fol-
lowing a sequence of a variable period of cold ischemia
and transplantation-related reperfusion of the donor
o r g a nh a sb e e ns h o w nt op l a ya ni m p o r t a n tr o l ew i t h
respect to the pathogenesis, resulting in an interstitial
and alveolar edema, injury of the blood-air barrier with
fragmentation of the alveolar epithelial lining and denu-
dation of the basement membrane [4]. Moreover,
marked dysfunctions of the intra-alveolar surfactant
obtained by means of broncho-alveolar lavage were
found after clinical lung transplantation and in animal
models of lung transplantation [5,6]. Surfactant is
synthesized, processed, stored and secreted by alveolar
epithelial type II cells (AE2 cells) and keeps the alveoli
open, dry and clean, meaning that it decreases the sur-
face tension towards zero upon compression at the end
of expiration and has both anti-edematous properties
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that alterations of the intra-alveolar surfactant system
occur in a model of ischemia/reperfusion injury in
regions which do not exhibit ultrastructural signs of an
injury of the blood-air barrier, indicating that inactiva-
tion of the intra-alveolar surfactant predates the forma-
tion of alveolar edema [11]. Consequentially, the
prophylactic administration of exogenous surfactant
turned out to have beneficial effects in models of ische-
mia/reperfusion injury [12,13] and lung transplantation
[14-17]. Oxidative stress has been shown to inactivate
surfactant and might therefore play a role in this model
of ischemia/reperfusion injury [18]. Bearing this in
mind, the choice of the preservation solution is of
importance, since solutions with low potassium concen-
trations were found to be associated with a reduced gen-
eration of reactive oxygen species compared to solutions
with high potassium concentrations, e.g. EuroCollins
solution [19,20]. Solutions with high potassium concen-
trations have been shown to depolarize smooth muscle
cells of the pulmonary arteries. This has been linked to
an increased release of reactive oxygen species by these
cells [19]. The AE2 cells play a crucial role in surfactant
homeostasis which is also reflected by the term “defen-
der of the alveolus” [21]. Surfactant, a material com-
posed of about 90% lipids and 10% proteins, is mostly
synthesized in the endoplasmatic reticulum and trans-
ferred by specialized transport proteins (e.g. ABCA3)
into the storing organelles, the so-called lamellar bodies
(Lb). Lb are surrounded by a limiting membrane and
share characteristics with lysosomes [22,23]. Both con-
stitutively and upon stimulation these lipids, tightly
packed to form lamellae filling the Lb, are secreted by
means of exocytosis, meaning that the limiting mem-
brane fuses with the cell membrane [24]. Cell stretch
and purinergic receptor activation (e.g. P2Y2 receptor)
via ATP are considered to be most potent stimuli of Lb
exocytosis under physiologic conditions, leading to an
increase of cytoplasmatic Ca
2+ concentration [25].
Taken together, an intra-cellular surfactant pool within
the AE2 cells can be distinguished from an intra-alveolar
surfactant pool [7], and alterations of the AE2 cells due
to ischemia/reperfusion injury might also be involved in
the pathogenesis of primary graft dysfunction following
clinical lung transplantation. An ultrastructural stereolo-
gical analysis of the AE2 cells of the contra-lateral
human donor lung (while the ipsilateral lung was trans-
planted) demonstrated that the alterations of intracellu-
lar surfactant were significantly associated with early
postoperative oxygenation and total intubation time
[26]. The intracellular surfactant appears to be a signifi-
cant structural determinant for early post-operative
morbidity and possibly also mortality following lung
transplantation. Experimental data derived from a rat
model of ischemia/reperfusion injury supports this
notion; the surfactant protein C expression was signifi-
cantly decreased within the first hours and days follow-
ing reperfusion and correlated with an impaired
oxygenation capacity [27]. This emphasizes that AE2
cells and changes of the intracellular surfactant pool are
important determinants for pulmonary function in this
model. In a previous study using an established animal
model of ischemia/reperfusion injury we observed a sig-
nificant reduction of active intra-alveolar surfactant
components, e.g. tubular myelin [11]. This observation
raised the question, whether there is an additional dys-
function of AE2 cells leading to an inhibition of Lb
secretion with subsequent reduction of active surfactant
subtypes in the alveolus. In turn, an increased exocytosis
of Lb would imply a physiologic response of the AE2
cells which attempt to stabilize the pool of active sub-
types within the alveolar space. Therefore, the present
study was designed to analyze changes of the intracellu-
lar surfactant pool, defined as the total amount of Lb
within the AE2 cells. We made use of a well established
rat model of ischemia/reperfusion injury mimicking the
complete scenario of transplantation related procedures,
namely flush perfusion, cold ischemia as well as the
reperfusion period including mechanical ventilation and
performed a design-based stereological analysis at the
ultrastructural level [4,11]. We hypothesized that in this
model an increased exocytosis of Lb occurs.
Materials and methods
Animal model
All animals were handled in accordance with the “Prin-
ciples of Laboratory Animal Care”,w h i c hw e r e
addressed by the National Society for Medical Research
and the G u i d ef o rt h eC a r ea n dU s eo fL a b o r a t o r yA n i -
mals, published by the National Institutes of Health
(NIH publication 85-23, revised 1996). All experiments
were approved by the bioethical committee of the dis-
trict of Lower Saxony.
Ten male adult Sprague-Dawley rats were randomly
assigned to two groups, 5 animals each. The first group
was subjected to ischemia/reperfusion (I/R) (flush perfu-
sion with Euro-Collins solution, ischemia for 2 h at 4°C
and reperfusion for 40 min), the second group served as
control and was immediately fixed after dissection of
the pulmonary artery. The experimental procedure
regarding the ischemia/reperfusion model has been
described in detail elsewhere [4,12,28]. By administration
of Pentobarbital (12 mg per 100 g body weight) intra-
peritonially in a lethal dosage, rats were sacrificed and a
tracheotomy was performed followed by endotracheal
intubation and mechanical ventilation with room air.
Tidal volumes were 5 ml with a positive end-expiratory
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40/min (4601, Rhema Labortechnik, Hofheim, Ger-
many). A median laparotomy was carried out followed
by a systemic heparinisation and a bilateral longitudinal
thoracotomy during mechanical ventilation. The pul-
monary artery was catheterized and flushed with 20 ml
of Euro-Collins solution (K
+ 115 mmol/l, Na
+ 10 mmol/
l, Cl
- 15 mmol/l, PO4 57.5 mmol/l, Glucose 3.5%, 355
mOsmol/l) at a constant perfusion pressure of 20 cm
H2O at 4°C. After perfusion, the mechanical ventilation
was ceased and the ischemic period followed. The heart-
lung block was excised and stored for 2 hours at 4°C in
30-40 ml of the preservation solution. The ischemia was
followed by a reperfusion phase lasting 40 min during
which the mechanical ventilation was continued. Using
a quattro head roller pump (Mod-Reglo-Digital; Ismatec,
Zurich, Switzerland) and bovine erythrocytes in Krebs-
Henseleit buffer (hematocrit 38-40%) the lungs were
reperfused. Deoxygenated Krebs-Henseleit buffer (95%
N2,5 %C O 2)w a si n f u s e di n t ot h er i g h ta t r i u ma n da
constant pressure within the left atrium of 2 cm H2O
was maintained during the whole procedure. In order to
monitor the gas-exchange capacity of the lung, the oxy-
gen uptake, defined as the dif f e r e n c ei no x y g e np a r t i a l
pressure pO2 between left and right atrium, was calcu-
lated at 10 and 40 min during reperfusion phase. More-
over, the peak inspiratory pressure (PIP) to maintain a
tidal volume of 5 ml was recorded. The functional data
of these experiments have been published in detail pre-
viously [11].
Sampling and tissue preparation
The left rat lungs were fixed by vascular perfusion via
the pulmonary artery with a mixture of 1.5% glutaralde-
hyde, 1.5% paraformaldehyde in 0.1 M Na cacodylate
buffer at a constant hydrostatic pressure of 15 cm H2O.
During fixation a constant positive airway pressure of
10-12 cm H2O was maintained after 2 respiratory cycles
so that the inflation degree was comparable and corre-
sponded approximately to 80% total lung capacity [29].
Regarding the lungs of the control group which were
not subjected to ischemia/reperfusion, the time between
preparation and perfusion fixation was approximately 5
min, limiting the ischemic period of these lungs to a
minimum. After storage of the lungs in fixative for at
least 24 hours, the total lung volume (V(lung)) was
determined by means of fluid displacement [30]. After-
wards a systematic uniform randomization was per-
formed in order to guarantee that every part of the lung
had the same chance of being included in the stereologi-
cal evaluation so that the whole organ was represented
[31]. Briefly, the whole lung was embedded in agar and
cut in 3 mm thick slices using a tissue slicer. Once
every even, once every uneven slab was further
processed in order to obtain appropriate samples for
electron microscopy. A transparent point grid was
superimposed on each slab and if a point hit the cut
surface of the slab, a small tissue block was excised for
electron microscopy. Doing this, 5 to 11 tissue blocks
per lung were obtained.
Afterwards, the tissue blocs designated for electron
microscopy were postfixed in osmium tetroxide, stained
en bloc in half saturated aqueous uranyl acetate, dehy-
drated in a rising acetone series and embedded in Ara-
ldite
® (Serva Electrophoresis, Heidelberg; Germany;
polymerization at 60°C over 5 days). Sectioning was per-
formed using an ultramicrotome (Ultracut E, Leica, Ben-
sheim, Germany). The first and the fourth section of a
consecutive row of 1 μm thick semithin sections were
mounted on one glass slide and stained with toluidine
blue for light microscopy. Afterwards, ultrathin sections
with a thickness of approximately 100 nm were cut and
two consecutive sections were placed on one slot grid
for electron microscopic evaluation. Ultrathin sections
were stained with lead citrate and uranyl acetate using
an Ultrastainer (Leica).
Design-based stereology
All methods applied in this study were in line with the
recently published ATS/ERS consensus statement on
quantitative assessment of lung structure [32]. Accord-
ing to the concept of a cascade sampling design, volume
fractions or densities of the structure of interest within
a known reference volume (in general the total lung
volume) were determined by means of point and inter-
section counting and converted to absolute values in
order to avoid the reference trap [31].
Light microscopic evaluation was carried out using an
Axioscope light microscope (Zeiss, Oberkochen, Ger-
many) equipped with a computer-assisted stereology
toolbox (CAST 2.0; Olympus, Ballerup, Denmark). At
light microscopic level, the number of AE2 cells per lung
(N(AE2, lung)) and the volume-weighted mean volume
of AE2 cells in one of the sections were determined using
the physical disector method [33] and the planar rotator
method [34], respectively. Taking the first and the fourth
section of a consecutive row of 1 μm thick semithin sec-
tions into account, the occurrence of a nucleolus within
an AE2 cell was defined as a counting event. Doing this,
the physical disector with the disector height of 3 μm
was used by counting in both directions, e.g. each section
was once the reference-section and once the look-up sec-
tion. For each AE2 cell counted this way, the individual
cell volume was estimated applying the planar rotator,
resulting in the number-weighted mean volume of AE2
cells (νN(AE2)). The total volume of all AE2 cells taken
together per lung served as the reference volume regard-
ing the electron microscopic analysis.
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tron microscope, CEM 902, Zeiss, Oberkochen),
approximately 100 AE2 cells per lung were systemati-
cally sampled and the profiles of these AE2 cells gener-
ated on the two adjacent ultrathin sections were
recorded in order to obtain a physical disector at the
electron microscopic level. The disector height was
determined individually by measuring the thickness of
folds in the section and dividing this thickness by two.
The counting event was defined as the occurrence of a
new Lb within an AE2 cell counting in both directions
[35,36]. In addition, by superimposing a coherent com-
b i n e dp o i n ta n dl i n eg r i dt e s t - s y s t e mo no n eo ft h e s e
profiles of AE2 cells, volume fractions of the Lb (VV(Lb,
AE2)), mitochondria and nuclei were determined. All
points falling on the profile of the AE2 were used to cal-
culate the disector volume, so that the numerical density
of Lb within AE2 cells (NV(Lb/AE2)) was obtained.
Moreover, intersection counting was used in order to
determine the luminal (S(lumen, AE2)) and total surface
area (S(cell, AE2)) of AE2 cells. As the number-weighted
mean volume of AE2 cells and their total number per
lung was known, densities were converted into absolute
values, e.g. number of Lb per AE2 (N(Lb, AE2)) or
volume of Lb per AE2 (V(Lb, AE2)) and per lung (V(Lb,
lung)). The number-weighted mean volume of Lb (νN
(Lb)) was calculated by dividing the total volume of Lb
per lung by the total number of Lb per lung.
Statistics
Statistical evaluation and plotting of data was performed
using GraphPad PRISM 5.0 for Windows (GraphPad
Software Inc., Software MacKiev). Between group differ-
ences were regarded as statistically significant if the p-
value obtained from unpaired t-test was < 0.05 and a
Gaussian approximation was present. Otherwise a U-test
was carried out. In order to characterize the relationship
between the luminal surface area of AE2 cells and the
total surface area of the limiting membrane of AE2 cells
a Pearson correlation analysis was carried out followed
by a linear regression. A p-value below 0.05 was consid-




Figure 1 demonstrates representative electron micro-
scopic findings in the control and Figure 2 in the I/R
group. The lungs of the control group were evenly
inflated without any signs of atelectasis/microatelectasis.
The alveolar walls were not swollen, the capillaries
widened and nearly completely free of blood cells as a
consequence of the perfusion fixation. The blood-air
barrier was intact and the integrity of the alveolar
epithelium as well as the capillary endothelium were
maintained. Alveolar or interstitial edema formations
were nearly completely absent in this group, which was
in line with a very short ischemic period during tissue
harvest. Inflammatory cells were absent. The cuboidal
AE2 cells were observed in their typical location in the
corners of the alveoli and characterized by the presence
of Lb and microvilli. The intra-alveolar surfactant was
dominated by multilamellated vesicles and lamellar
body-like structures, the sub-fractions known to possess
surface active properties. From an ultrastructural point
of view, the criteria for a successful perfusion fixation
were fulfilled [37].
In contrast, marked injury of the blood-air barrier was
observed in the lungs having been subjected to ische-
mia/reperfusion injury. In some regions, the basement
membrane was denuded with a lifted or fragmented
alveolar epithelial lining. Apoptotic and necrotic alveolar
epithelial cells, including AE2 cells were observed occa-
sionally. In other regions, a swelling of the alveolar
epithelial or capillary endothelial cells was seen. More-
over, both at light and at electron microscopic level, a
protein-rich alveolar edema was found. Regarding the
AE2 cells and their intracellular surfactant pool, defined
Figure 1 Representative micrograph showing an AE2 cell with
normal blood-air barrier in a control lung. The ultrastructure of
the AE2 cell is characterized by the existence of lamellar bodies (LB).
A luminal surface to the alveolar space can be distinguished from
the baso-lateral surface adjoining the basement membrane.
Furthermore, mitochondria (M), the endoplasmatic reticulum (ER),
the nucleus (N) as well as the nucleolus (Nu) are visible. The alveolar
space (Alv) and the capillary lumen (Cap) are separated by the very
slim and intact blood-air barrier consisting of the alveolar epithelial
cells, basement membrane and capillary endothelial cells. Scale bar:
5 μm.
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could be observed between the control group and the I/
R group, emphasizing the need for the design-based
stereological approach applied in the current study.
Quantitative analysis
The stereological results are illustrated in Figures 3 and
4. Both the total number of AE2 cells and the number-
weighted mean volume of AE2 cells did not differ
between control and I/R group, so that the reference
volume for the subsequent ultrastructural stereological
evaluation was equal. At the electron microscopic level,
however, marked differences with respect to the intra-
cellular surfactant system could be traced. The total
volume of lamellar bodies per AE2 cell was slightly but
not statistically significantly decreased after ischemia/
reperfusion injury compared to the control group. How-
ever, the total number of Lb per AE2 cell was markedly
and significantly reduced after ischemia/reperfusion
injury. The number-weighted mean volume of Lb on
the other hand indicated a tendency towards higher
values in the I/R group reducing the difference with
respect to the total volume of Lb per AE2 cell between
the control and I/R group. The total surface area of the
AE2 cells (both luminal and baso-lateral surface taken
together) did not differ between these two groups. How-
ever, the contribution of the luminal surface to the com-
plete surface of the AE2 cells was significantly higher in
the I/R group compared to the control group.
Assuming that a Lb is a sphere, the radius and subse-
quently the mean surface per Lb and the total surface
area of the limiting membrane of Lb per AE2 cell can
be calculated, as the mean number of Lb per cell was
known. These data are shown in Figure 5 in comparison
to the mean luminal surface area per AE2 cell. The total
surface area of Lb per cell was significantly higher in the
control group compared to the I/R group. The mean of
the total surface of Lb per AE2 was 204 μm
2 (95% confi-
dence interval 148-259 μm
2) in the control group but
only 141 μm (95% confidence interval 112-171 μm
2)i n
the I/R group (p = 0.02). On the contrary, the mean
luminal surface area per AE2 was significantly smaller in
the control group. The mean luminal surface area per
AE2 was 149 μm
2 (95% confidence interval 87-212 μm
2)
in the control group and 227 μm
2 (95% confidence
interval 188-265 μm
2) in the I/R group (p = 0.02). The
differences in the mean of the total surface area of Lb
per AE2 cell (63 μm
2) and total luminal surface area per
AE2 cell (78 μm
2) between control and I/R were equiva-
lent in both groups.
A significantly negative correlation between the total
surface area of the limiting membrane of Lb and the
luminal surface area per AE2 cell (r = -0.77, p < 0.01)
was present as shown in Figure 6; the higher the luminal
surface per AE2 cell was, the lower the total surface area
of the limiting membrane of Lb per AE2 cell. According
to linear regression analysis, this relationship can be
described by approximation using the following formula:
Y = 293-0.64X.
Discussion
Primary graft dysfunction is a dreaded complication fol-
lowing clinical lung transplantation affecting both short-
and long-term morbidity and mortality of patients [1,2].
Surfactant alterations in both the intra-alveolar and
intracellular surfactant system have been recognized as
important determinants of post operative graft function
and morbidity of the patients [14,26]. The ischemia/
reperfusion injury is an acknowledged mechanism
involved in the development of primary graft dysfunc-
tion and known to inactivate the intra-alveolar surfac-
tant [11,12], which can be compensated by the
prophylactic intratracheal administration of exogenous
surfactant preparations [13,38]. However, little is known
with respect to the changes of the intracellular
Figure 2 Representative micrograph demonstrating typical
features of injury observed in the I/R group. The AE2 cell
contains Lb, M, ER and N. A multi-vesicular body (MV) is visible. With
respect to AE2 cell ultrastructure, no obvious differences can be
seen compared to the AE2 cell shown in Figure 1. The alveolar
space is filled with alveolar edema (ed) and erythrocytes (ery). The
blood-air barrier is damaged as indicated by the fragmented
alveolar epithelial lining (*) including areas with denuded basement
membrane. Scale bar: 5 μm.
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differences could be found with respect to the total number of AE2 cells (N(AE2, lung)) (3A) and the number-weighted mean volume of AE2
cells (νN AE2)) (3B). However, the mean luminal surface of AE2 cells was significantly lower in the control group than in the I/R group (3C),
whereas the total surface per AE2 cell did not differ between the 2 groups.
Figure 4 Data related to Lb. Each individual value per lung, the mean and the standard error of the mean are shown. There was no significant
difference between the two groups regarding the total amount of Lb per lung (4A) or per cell (4B), although a tendency towards lower volumes
was visible after I/R injury (4B). However, the total number of Lb per AE2 cell was significantly decreased in the lungs having been subjected to
the I/R protocol (4C). There was a trend towards higher number-weighted mean volumes of Lb in the I/R group (4D) which did not reach
statistical significance.
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such as the amount of Lb. Although it has been shown
that the prophylactic delivery of exogenous surfactant
preparations via the trachea has no impact on the
amount of the intracellular surfactant pool [39], recent
data suggest that alterations of the intracellular surfac-
tant can occur already during the early phase following
ischemia/reperfusion injury [27]. Considering the
volume-to-surface ratio of Lb as a measure of the mean
“thickness” of Lb, a highly significant correlation could
be recognized with the total intubation time following
clinical lung transplantation; the higher the volume-to-
surface ratio of Lb in the contralateral lung was, the
longer the post-operative intubation time [26]. In addi-
tion, the need for oxygen supplementation after clinical
lung transplantation, e.g. the fraction of inspired oxygen
FiO2, correlated inversely with the volume-to-surface
ratio of Lb [26], indicating that the smaller the Lb were
the less the need for additional oxygen. In the present
study, we carried out a detailed analysis of the intracel-
lular surfactant pool, choosing a design-based stereologi-
cal approach at the light and electron microscopic level.
We found a significant decrease in the number of Lb
per AE2 cell accompanied by a slight but not significant
increase in the number-weighted mean volume of Lb.
The size of the Lb seems to be relevant in terms of clin-
ical lung transplantation [26]. In a previous study using
this animal model of transplantation related procedures,
the oxygen up-take during reperfusion was very much
impaired and the difference in PO2 between left atrium
and pulmonary artery was only 13 mmHg at 40 min
[11]. Thus, the alterations of the intracellular surfactant
pool observed in the present study seem to be linked
with an impaired gas-exchange capacity of the lung in
this model. Although the total volume of all Lb per lung
taken together did not differ between control and I/R
groups, there was a clear trend towards a decline of the
total volume of Lb per AE2 cell. Furthermore, we
observed a significant increase in the luminal surface
area per AE2 cell as a consequence of ischemia/reperfu-
sion, which demonstrated a strong negative correlation
with the calculated total surface area of the limiting
membrane of Lb per AE2 cell. Following a period of
prefusion and hemifusion, the limiting membrane of Lb
fuses with the luminal cellular surface of the AE2 cell
and releases its content, the surfactant material, into the
hypophase of the alveolus by exocytosis [24,40]. Thus,
our data strongly suggest an increased exocytosis of Lb
in the lungs having been subjected to the sequence of
lung transplantation-related events, e.i. cold ischemia
and reperfusion combined with a period of mechanical
ventilation. This would lead to a reduction of their
number per cell and subsequently an increase of the
luminal surface area of the AE2 cells due to a fusion of
the limiting membrane with the luminal cellular mem-
brane. Interestingly, the total volume of Lb per AE2 cell
showed only a marginal difference between the two
Figure 5 Comparison of the luminal surface area of AE2 cells
(S(lumen, AE2)) and the assumption-based calculated total
surface area of the limiting membrane of Lb per AE2 cell (S(LB,
AE2)) between the control group and the I/R group. Whereas
the total surface of the limiting membrane was higher than the
luminal surface area per AE2 cell in the control group, it was the
other way round in the I/R group. The mean sum of S(lumen, AE2)
and S(LB, AE2) within the control group was 353 μm
2 (95% CI 326-
380 μm
2) which was comparable to the mean sum of S(lumen, AE2)
and S(LB, AE2) in the I/R group of 368 μm
2 (95% CI 308-428 μm
2).
This fact indicates that there was a shift of the limiting membrane
to the luminal surface area due to exocytosis of Lb. Level of
significance: control S(Lb, AE2) vs. I/R S(Lb, AE2) p = 0.02; control S
(lumen, AE2) vs. I/R S(lumen, AE2) p = 0.02.
Figure 6 Linear regression demonstrates a negative correlation
of the calculated total surface area of the limiting membrane
of Lb per AE2 cell and the luminal surface area of AE2 cells.
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increased number-weighted mean volume of Lb after
ischemia/reperfusion injury, meaning that AE2 cells
contain fewer but larger Lb. The reason for this might
be an increased de novo synthesis of surfactant or an
up-regulated recycling of inactive surfactant compo-
nents, e.g. unilamellated vesicles from the alveolar space,
which is the most abundant sub-fraction in this model
[11,41], leading to an increased incorporation of surfac-
tant material in the existing Lb. However, the decreased
number of Lb accompanied by a slight increase in their
mean volume might be seen as an indirect indication of
an increased recycling rather than an increased de novo
synthesis of surfactant components. The elucidation of
the mechanisms responsible for the increased exocytosis
of Lb in this animal model was beyond the scope of this
study. However, mechanical factors including stretching
of the alveolar lining during ventilation have been recog-
nized as appropriate stimuli with respect to surfactant
secretion. In previous studies, a correlation between the
peak inspiratory pressure (PIP) and the amount of phos-
pholipids in broncho-alveolar lavage fluid was observed
in an isolated ventilated rat lung model, suggesting that
positive pressure ventilation results in surfactant secre-
tion [42]. Moreover, Massaro and Massaro described a
significant decrease of the volume fraction of Lb within
AE2 cells following mechanical ventilation and periods
of high tidal volumes compared to ventilation with nor-
mal tidal volumes, supporting the hypothesis of an
increased surfactant liberation [43]. In the present study,
the mean PIP needed to deliver a given tidal volume of
5 ml was quite high with 23.4 cmH2O at 10 min or 27.3
cmH2O at 40 min of the reperfusion phase [11] and
reflected a progressive restrictive ventilatory failure as a
consequence of ischemia/reperfusion injury. Thus,
although normal tidal volumes and a PEEP of 3 cmH2O
were administered, the increased liberation of Lb in our
study might at least in part be a consequence of the
mechanical ventilation. The dysfunction of intra-alveolar
surfactant can promote the formation of atelectasis.
Mechanical ventilation may induce shear stress of the
alveolar lining during reopening alveoli in the inspira-
tory cycle [44], which leads to an increased exocytosis of
Lb [25]. Our study was not designed to distinguish
whether the observed decrease in Lb number and lumi-
nal surface area per AE2 cell, which are postulated to
reflect an increased exocytosis of Lb, is a consequence
of the ischemia/reperfusion injury alone, of mechanical
ventilation or of a combination of both. Although it
remains a limitation of our study, one has to take into
account that in the clinical setting the graft will always
experience both ischemia/reperfusion injury and
mechanical ventilation.
Conclusion
In summary, we observed a marked decrease in the
number of Lb per cell accompanied by an increase of
t h el u m i n a ls u r f a c ea r e ao ft h eA E 2c e l l s ,w h i c hi sa n
indirect sign of a fusion of the limiting membrane with
the luminal surface. The total volume of Lb per AE2
cell and per lung remains stable, being at least in part a
consequence of a slight increase of the mean individual
volume of Lb. Hence, we provided evidence of an
increased exocytosis of Lb in this established rat model
of ischemia/reperfusion injury, which can be interpreted
as a mechanism to compensate in part for the loss of
active intra-alveolar surfactant. The therapeutic concept
of conserving pulmonary surfactant of donor lungs
designated for lung transplantation should take into
account the surfactant producing AE2 cells with the
containing intracellular surfactant pool. Thus, novel
therapeutic strategies in ischemia/reperfusion injury fol-
lowing lung-transplantation could also address an aug-
mentation of the production and exocytosis of lamellar
bodies.
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